News
EmailPrint

Search
Announcements/Press Releases
Media Mentions

Jennifer Manton
Chief Marketing Officer
212.407.4112

Cobalt's Generic Boniva Barred in Roche IP Spat

November 10, 2010 | Law360

Loeb & Loeb LLP and Mark Waddell are noted as counsel for Hoffmann-La Roche Inc. in the pharmaceutical company's successful bid for preliminary injunction barring Cobalt Pharmaceuticals Inc. from launching a generic version of the branded osteoporosis drug Boniva®.
This Web site may constitute "Attorney Advertising" under the New York Rules of Professional Conduct and under the law of other jurisdictions.
Your use of our Web site or its facilities constitutes your acceptance of the Terms of Use and Privacy Policy, which are accessible in the link at the bottom left of this page.